Progestin Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 50 mg/mL, 100 mg/mL

Reference Brands: Depo-subQ Provera 104(US)

Category: Oncology Cancer Care

Progestin Injection (50 mg/mL and 100 mg/mL) is used in oncology to treat hormone receptor-positive breast cancer, recurrent endometrial cancer, and manage palliative care symptoms. Approved in both the U.S. and EU, it works by blocking hormone receptors to slow tumor progression. Available in IM or subcutaneous formulations, it is essential for oncology B2B distribution, supporting cancer treatment centers and hospitals. Progestin Injection is available in Injection and strengths such as 50 mg/mL, 100 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Progestin Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Progestin Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Progestin Injection (50 mg/mL and 100 mg/mL), often in the form of Medroxyprogesterone acetate, is used in oncology to manage hormone receptor-positive breast cancer, recurrent endometrial cancer, and palliative care for various cancer symptoms. Approved in both the U.S. and EU, it plays a critical role in hormonal therapy, working to slow cancer progression by blocking hormone receptors. Available as an IM or subcutaneous injection, it is a key drug in oncology B2B distribution, supporting hospitals and cancer treatment centers with its ability to control tumor growth and improve patient quality of life.